NIAID Exercises Option to Continue Preclinical Development of Bolder BioTechnology’s BBT-059 IL-11 Analog to Treat Acute Radiation Syndrome

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
http://www.bolderbio.com/niaid-exercises-option-to-continue-preclinical-development-of-bolder-biotechnologys-bbt-059-il-11-analog-to-treat-acute-radiation-syndrome/
Research Institution
Bolder BioTechnology
Short Title
NIAID Exercises Option to Continue Preclinical
Content Coordinator
Claudia Wair
Content Manager
Jennifer Routh